首页> 美国卫生研究院文献>ACS AuthorChoice >c-Abl Tyrosine Kinase Adopts Multiple ActiveConformational States in Solution
【2h】

c-Abl Tyrosine Kinase Adopts Multiple ActiveConformational States in Solution

机译:c-Abl酪氨酸激酶采用多种活性解决方案中的构象态

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protein tyrosine kinases of the Abl family have diverse roles in normal cellular regulation and drive several forms of leukemia as oncogenic fusion proteins. In the crystal structure of the inactive c-Abl kinase core, the SH2 and SH3 domains dock onto the back of the kinase domain, resulting in a compact, assembled state. This inactive conformation is stabilized by the interaction of the myristoylated N-cap with a pocket in the C-lobe of the kinase domain. Mutations that perturb these intramolecular interactions result in kinase activation. Here, we present X-ray scattering solution structures of multidomain c-Abl kinase core proteins modeling diverse active states. Surprisingly, the relative positions of the regulatory N-cap, SH3, and SH2 domains in an active myristic acid binding pocket mutant (A356N) were virtually identical to those of the assembled wild-type kinase core, indicating that Abl kinase activation does not require dramatic reorganization of the downregulated core structure. In contrast, the positions of the SH2 and SH3 domains in a clinically relevant imatinib-resistantgatekeeper mutant (T315I) appear to be reconfigured relative to theirpositions in the wild-type protein. Our results demonstrate that c-Ablkinase activation can occur either with (T315I) or without (A356N)global allosteric changes in the core, revealing the potential forpreviously unrecognized signaling diversity.
机译:Abl家族的蛋白酪氨酸激酶在正常细胞调节中具有多种作用,并作为致癌融合蛋白驱动多种形式的白血病。在非活性c-Abl激酶核心的晶体结构中,SH2和SH3结构域停靠在激酶结构域的背面,从而形成紧凑的组装状态。该非活性构象通过肉豆蔻基化的N-帽与激酶结构域的C-叶中的口袋的相互作用而稳定。干扰这些分子内相互作用的突变导致激酶激活。在这里,我们介绍了模拟各种活跃状态的多域c-Abl激酶核心蛋白的X射线散射溶液结构。令人惊讶的是,活性肉豆蔻酸结合口袋突变体(A356N)中调节性N-cap,SH3和SH2结构域的相对位置实际上与组装的野生型激酶核心的相对位置相同,这表明不需要Abl激酶激活下调的核心结构的戏剧性重组。相反,在临床相关的伊马替尼耐药中,SH2和SH3结构域的位置网守突变体(T315I)似乎相对于其重新配置野生型蛋白质中的位置。我们的结果表明c-Abl(T315I)或不使用(A356N)均可发生激酶激活核心的全球变构变化,揭示了潜在的先前无法识别的信令多样性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号